期刊文献+

胸腔镜全肺切除治疗非小细胞肺癌的临床效果观察 被引量:4

Effect Observation of Total Lung Lobectomy for Non-Small Cell Lung Cancer
下载PDF
导出
摘要 目的:观察非小细胞肺癌(NSCLC)患者接受胸腔镜全肺切除术治疗后的预后疗效。方法:分析80例NSCLC患者的临床资料,对采取胸腔镜全肺切除术的NSCLC患者进行预后生存期的统计分析。结果:胸腔镜全肺切除术与术后放疗联合治疗NSCLC模式的患者生存期最长,超过了单纯胸腔镜全肺切除术组;全肺放疗+立体定向放疗NSCLC患者的生存期也优于单纯治疗。结论:肺部放疗与全身化疗、胸腔镜全肺切除术联合治疗是治疗NSCLC的最佳模式,全肺放疗和立体定向放疗联合治疗NSCLC相对更加有效。 Objective: To observe the prognosis of patients with non small cell lung cancer(NSCLC) treated by video assisted lobectomy.Methods: The clinical data of 80 patients with NSCLC were analyzed,and the statistical analysis of the survival time of the patients with NSCLC were performed.Results: Thoracoscopy after whole lung resection and postoperative radiotherapy in the treatment of the survival period in patients with NSCLC model of the long,more than the treated by thoracoscopic pneumonectomy group; whole lung radiotherapy + stereo orientation radiotherapy patients with NSCLC survival is better than pure treatment.Conclusion: Pulmonary radiotherapy combined with systemic chemotherapy and total lung resection is the best treatment for NSCLC,and NSCLC is more effective in combination with radiotherapy and stereotactic radiotherapy.
作者 陈思曈 李伟
出处 《中国医药导刊》 2016年第4期349-350,共2页 Chinese Journal of Medicinal Guide
关键词 非小细胞肺癌 胸腔镜全肺切除术 预后分析 生存期 Non small cell lung cancer Lobectomy Prognosis Survival time
  • 相关文献

参考文献10

二级参考文献45

  • 1王思愚,区伟,洪文善,林勇斌.Iressa治疗非小细胞肺癌脑转移[J].中国肺癌杂志,2004,7(4):329-330. 被引量:6
  • 2AndrewsDW ScottCB SperdutoPW FlandersAE GasparLE SchellMC Werner-WasikM DemasW RyuJ BaharyJP SouhamiL RotmanM MehtaMP CurranWJJr.Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase Ⅲ resuIts of the RTOG 9508 randomised trial[J].中国神经肿瘤杂志,2004,2(3):192-192. 被引量:216
  • 3Tsao M Lloyd N Wong R Chow E Rakovitch E Laperriere N.Whole brain radiotherapy for the treatment of multiple brain metastases[J].中国神经肿瘤杂志,2006,4(2):99-99. 被引量:17
  • 4Furuse K, Kamimori T, Kawahara M, et al. A pilot study of concurrent whole-brain radiotherapy and chemotherapy combined with cisplatin, vindesine and mitomycin in non-small-cell lung cancer with brain metastasis. Br J Cancer, 1997,75(4) : 614-618. 被引量:1
  • 5Cappuzzo F, Ardizzoni A, Soto-Parra H,et al. Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from nonsmall cell lung cancer (NSCLC). Lung Cancer,2003,41(2) : 227-231. 被引量:1
  • 6Nabid A, Kresl J, Stea B, et al. Standard whole brain radiation (WBRT) with supplemental oxygen (O2) with or without RSR13 (efaproxiral) in patients with brain metastases originating from NSCLC: Results of a subgroup analysis. J Clin Oncol,2004,22(14Suppl 被引量:1
  • 7Russell AH, Pajak TE, Selim HM, et al.Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat 被引量:1
  • 8Stuschke M, Eberhardt W, Pottgen C, et al. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term followup and investigations of late neuropsychologic effects. J Clin Oncol, 1999, 17(9):270 被引量:1
  • 9Alexander S, Hannah C, Andrea B, et al.Brain metastases as the initial site of failure in locally advanced non-small cell lung cancer treated with combined modality therapy: implications for prophylactic cranial irradiation. Lung cancer, 2003,41 Suppl2: 2 被引量:1
  • 10Zabel A, Milker-Zabel S, Thilmann C, et al. Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors. Lung Cancer,2002,37(1): 87-94. 被引量:1

共引文献63

同被引文献17

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部